May 2017

Safety Related Changes

Zydelig (idelalisib) can cause serious infections and fatal pneumonitis. The increased risk of infection may be due to immunomodulatory effects of the drug. Most frequently observed were infections in the respiratory system and septic events.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au